Eric Cheah

Eric Cheah is a skilled scientist with a robust background in preclinical research and translational sciences. Currently serving as a Senior Associate Scientist at Generation Bio since April 2023, Eric previously held positions at Magenta Therapeutics, where significant contributions included the development and optimization of experiments related to a novel antibody drug conjugate for hematopoietic stem cell transplants and detailed internalization kinetics of MGTA-117. Earlier roles involved extensive research in immunophenotyping and in vivo pharmacology studies at Brigham and Women's Hospital, as well as positions focused on compliance and automated cell culture systems at HuaCells Corporation and in academics at Northeastern University. Eric Cheah holds a Master of Science in Biotechnology and a Bachelor of Science in Biochemistry from Northeastern University.